Tags

Type your tag names separated by a space and hit enter

Improved survival after introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms.
J Vasc Surg. 2007 Mar; 45(3):443-50.JV

Abstract

BACKGROUND

The study was conducted to demonstrate improved survival (30-day mortality) after the introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms (rAAA). Numerous authors have successfully demonstrated reduced mortality in patients with rAAA using endovascular techniques. Comparison of endovascular aneurysm repair (EVAR) with open repair for rAAA may be misleading, however, because EVAR cannot be performed on all patients, and selection bias may explain the superior performance of any given surgical or endovascular strategy. We developed a model to predict mortality in patients before the introduction of EVAR (preprotocol population), applied this model to predict 30-day mortality among prospective patients (postprotocol population), and compared observed vs expected results.

METHODS

We assessed 126 patients with rAAA. Primary outcome was 30-day mortality. Potential confounding variables were age, sex, presurgical lowest recorded systolic blood pressure (SBP), and glomerular filtration rate (GFR). A logistic regression model incorporating significant confounders was used to evaluate changes in 30-day mortality for all patients with rAAA after introduction of the EVAR protocol. Separate logistic regressions were done to compare 30-day mortality for preprotocol vs patients receiving EVAR and preprotocol vs patients receiving postprotocol open repair. Cumulative sum (CUSUM) analysis was used to assess shifts in the performance of the rAAA program over time.

RESULTS

Significant confounders were SBP, absence of SBP, and GFR. Logistic regression found evidence of lower mortality after the protocol was introduced, 17.9% vs 30.0% (odds ratio [OR], 0.385; 95% confidence interval [CI], 0.141 to 0.981; P = .046). Comparison of all open repairs (preprotocol and postprotocol) and EVAR demonstrated decreased risk for EVAR of 5.0% vs 28.3% (OR, 0.109; 95% CI, 0.013 to 0.906; P = .0084). Unstable patients (SBP <or=80) showed a trend towards improved survival with EVAR relative to open repair (14.3% vs 56.0%, P = .061). Comparison of preprotocol surgery with open repair after the introduction of the protocol found no evidence of a difference between mortality rates for the open procedures-30.0% (preprotocol) vs 25.0% (postprotocol; OR, 0.688; 95% CI, 0.335 to 1.415, P = .3031)-demonstrating that the improved performance observed with CUSUM analysis was related to the introduction of the EVAR protocol.

CONCLUSION

Our predictive model using "weighted" CUSUM analysis (a measure of performance over time) demonstrated that a predefined strategy of management of rAAA that includes EVAR is associated with improved (P < .05) mortality. Unstable patients with rAAA may be particularly benefited by EVAR and should not be excluded from repair. Appropriate patients with rAAA who are undergoing treatment in experienced vascular centers should be offered EVAR as the treatment of choice.

Authors+Show Affiliations

Division of Vascular Surgery, Department of Surgery, University of Calgary, Calgary, Alberta, Canada. randyd.moore@calgaryhealthregion.caNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

17257800

Citation

Moore, Randy, et al. "Improved Survival After Introduction of an Emergency Endovascular Therapy Protocol for Ruptured Abdominal Aortic Aneurysms." Journal of Vascular Surgery, vol. 45, no. 3, 2007, pp. 443-50.
Moore R, Nutley M, Cina CS, et al. Improved survival after introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms. J Vasc Surg. 2007;45(3):443-50.
Moore, R., Nutley, M., Cina, C. S., Motamedi, M., Faris, P., & Abuznadah, W. (2007). Improved survival after introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms. Journal of Vascular Surgery, 45(3), 443-50.
Moore R, et al. Improved Survival After Introduction of an Emergency Endovascular Therapy Protocol for Ruptured Abdominal Aortic Aneurysms. J Vasc Surg. 2007;45(3):443-50. PubMed PMID: 17257800.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Improved survival after introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms. AU - Moore,Randy, AU - Nutley,Mark, AU - Cina,Claudio S, AU - Motamedi,Mona, AU - Faris,Peter, AU - Abuznadah,Wesam, Y1 - 2007/01/25/ PY - 2006/10/01/received PY - 2006/11/18/accepted PY - 2007/1/30/pubmed PY - 2007/3/31/medline PY - 2007/1/30/entrez SP - 443 EP - 50 JF - Journal of vascular surgery JO - J Vasc Surg VL - 45 IS - 3 N2 - BACKGROUND: The study was conducted to demonstrate improved survival (30-day mortality) after the introduction of an emergency endovascular therapy protocol for ruptured abdominal aortic aneurysms (rAAA). Numerous authors have successfully demonstrated reduced mortality in patients with rAAA using endovascular techniques. Comparison of endovascular aneurysm repair (EVAR) with open repair for rAAA may be misleading, however, because EVAR cannot be performed on all patients, and selection bias may explain the superior performance of any given surgical or endovascular strategy. We developed a model to predict mortality in patients before the introduction of EVAR (preprotocol population), applied this model to predict 30-day mortality among prospective patients (postprotocol population), and compared observed vs expected results. METHODS: We assessed 126 patients with rAAA. Primary outcome was 30-day mortality. Potential confounding variables were age, sex, presurgical lowest recorded systolic blood pressure (SBP), and glomerular filtration rate (GFR). A logistic regression model incorporating significant confounders was used to evaluate changes in 30-day mortality for all patients with rAAA after introduction of the EVAR protocol. Separate logistic regressions were done to compare 30-day mortality for preprotocol vs patients receiving EVAR and preprotocol vs patients receiving postprotocol open repair. Cumulative sum (CUSUM) analysis was used to assess shifts in the performance of the rAAA program over time. RESULTS: Significant confounders were SBP, absence of SBP, and GFR. Logistic regression found evidence of lower mortality after the protocol was introduced, 17.9% vs 30.0% (odds ratio [OR], 0.385; 95% confidence interval [CI], 0.141 to 0.981; P = .046). Comparison of all open repairs (preprotocol and postprotocol) and EVAR demonstrated decreased risk for EVAR of 5.0% vs 28.3% (OR, 0.109; 95% CI, 0.013 to 0.906; P = .0084). Unstable patients (SBP <or=80) showed a trend towards improved survival with EVAR relative to open repair (14.3% vs 56.0%, P = .061). Comparison of preprotocol surgery with open repair after the introduction of the protocol found no evidence of a difference between mortality rates for the open procedures-30.0% (preprotocol) vs 25.0% (postprotocol; OR, 0.688; 95% CI, 0.335 to 1.415, P = .3031)-demonstrating that the improved performance observed with CUSUM analysis was related to the introduction of the EVAR protocol. CONCLUSION: Our predictive model using "weighted" CUSUM analysis (a measure of performance over time) demonstrated that a predefined strategy of management of rAAA that includes EVAR is associated with improved (P < .05) mortality. Unstable patients with rAAA may be particularly benefited by EVAR and should not be excluded from repair. Appropriate patients with rAAA who are undergoing treatment in experienced vascular centers should be offered EVAR as the treatment of choice. SN - 0741-5214 UR - https://www.unboundmedicine.com/medline/citation/17257800/Improved_survival_after_introduction_of_an_emergency_endovascular_therapy_protocol_for_ruptured_abdominal_aortic_aneurysms_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0741-5214(06)02157-4 DB - PRIME DP - Unbound Medicine ER -